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Purpose: To determine whether the polymorphisms of calcitonin receptor-like receptor gene (CALCRL) are associated
with primary angle closure glaucoma (PACG) in a southern Chinese population.
Methods: A total of 207 individuals with acute and chronic PACG and 205 ethnically matched controls were recruited
in the current study. A tag-single nucleotide polymorphism approach was used to investigate this gene. Alleles were
determined by PCR restriction fragment length polymorphism.
Results: The results show a nominal association between rs1157699 and acute PACG (uncorrected p=0.024 and 0.028
for alleles and genotypes, respectively). Haplotype Trs840617Crs6759535Trs1157699 frequency is significantly higher in acute
PACG  patients  than  in  controls  (corrected  p=0.012),  whereas  haplotype  Trs840617Crs6759535Crs1157699  frequency  is
significantly lower in acute PACG patients compared with controls (corrected p=0.02). However, no significant difference
was detected between chronic PACG and CALCRL tag single nucleotide polymorphisms.
Conclusions: The study suggests a possible role of CALCRL in the pathogenesis of acute PACG but not chronic PACG.
A replication of this study with a larger sample size as well as on different populations will be helpful in confirming this
finding.
Glaucoma  is  the  second  leading  cause  of  blindness
worldwide,  and  60  million  people  will  have  open  angle
glaucoma and angle closure glaucoma (ACG) by 2010 [1].
Primary angle closure glaucoma (PACG) is the most common
type of glaucoma in the Asian population and is responsible
for the vast majority of bilateral glaucoma blindness in China
[2]. PACG can be divided into an acute or chronic form. Acute
PACG (APACG) has a rapid onset, dramatic symptoms, and
severe elevation of intraocular pressure (IOP), while chronic
PACG  (CPACG)  is  latent—the  presence  of  peripheral
anterior synechiae is gradually formed, resulting in visual
field  defects.  Although  their  manifestations  are  different,
APACG and CPACG share similar anatomical characteristics
and both are caused by factors that either pull or push the iris
up into the angle, physically blocking the drainage of aqueous
humor and raising IOP [3].
Predisposing factors for PACG are mainly related to the
geometry of the anterior chamber, such as a shallow anterior
chamber, narrow angle, lens position, lens thickness, and short
axial length [4]. Other risk factors include age, female sex,
and family history [5]. Lowe [6] suggested that the action of
a large number of grouped or independently inherited genes
results in anterior chamber shallowness. However only 10%
of people with anatomically narrow angles develop PACG
[7]. Therefore other factors may alter the degree of pupillary
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block,  thus  triggering  a  PACG  attack.  Because  the
pathogenesis of PACG is complex, there has been no single
or  combination  of  parameters  that  is  sensitive  enough  to
predict whether eyes with a shallow anterior chamber and
“occludable angle” will develop PACG.
Perhaps, it is reasonable to expect that genes involving
development  and  functioning  of  the  anterior  segment
participate in the geometry of the anterior chamber. A number
of lines of evidence have suggested that both genetic and
environmental factors contribute to the development of PACG
[6]. PACG, as a common complex disease [8], has become an
important target for association studies in recent years. PACG
is associated with genes related to regulation of axial length
and  structural  remodeling  of  connective  tissues,  such  as
membrane-type frizzled-related protein (MFRP) gene, matrix
metalloproteinase  9  (MMP-9)  gene,  and
methylenetetrahydrofolate reductase (MTHFR) gene [9-13].
The biological significance of the associated single nucleotide
polymorphisms (SNPs) in the development of PACG is still
unknown  [9].  However  such  association  has  not  been
replicated in subsequent research [10,11].
Recently, a transgenic mouse model for acute ACG was
generated by Lars et al. [14]. Overexpression of calcitonin
receptor-like receptor (CALCRL) in the pupillary sphincter
muscle resulted in pupillary palsy and acutely and transiently
elevated IOP in mice, mimicking the characteristic phenotype
of acute PACG in humans. It is unknown whether genetic
variations in CALCRL are associated with PACG.
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between tag SNPs of CALCRL and PACG (both APACG and
CPACG) in a southern Chinese population.
METHODS
Patient  recruitment  and  assessment:  Unrelated  PACG
patients  and  control  subjects  were  recruited  from  the
Zhongshan  Ophthalmic  Center  of  Sun  Yat-sen  University
(Guangzhou, China). The study subjects consisted of 207
patients with PACG (including 139 females and 68 males ,
age  50-80)  and  205  unaffected  controls  (including  138
females and 67 males , age 43-95). Written informed consent
was obtained from all subjects, and the study had the approval
of  the  Ethics  Committees  of  the  Zhongshan  Ophthalmic
Center  and  was  performed  according  to  the  tenets  of  the
Declaration of Helsinki. All control subjects were matched by
age and gender with the patients. All study subjects were Han
Chinese from southern China.
PACG was defined according to the International Society
of  Geographical  and  Epidemiologic  Ophthalmology
classification by Foster et al. [15]. PACG subjects were further
categorized into two groups: APACG and CPACG.
The diagnosis of APACG was based on the following
criteria:
(1) the presence of at least two symptoms: eye pain,
headache, blurred vision, and vomiting;
(2) the presence of at least three of the following signs:
conjunctival  congestion,  corneal  epithelial  edema,  mid-
dilated unreactive pupil, glaucomflecken, and iris atrophy;
(3) 270° or greater of anterior chamber angle closure on
gonioscopic examination;
(4) IOP >40 mmHg by Goldmann applanation tonometry.
The diagnosis of CPACG was based on the following
criteria:
(1)  the  presence  of  glaucomatous  optic  neuropathy,
which was defined as a cup-to-disc ratio ≥0.7 or asymmetry
≥0.2 between the two eyes, neuroretinal rim width reduced to
≤0.1 cup-to-disc ratio, and nerve fiber layer defect;
(2) visual field loss detected with static automated white-
on-white threshold perimetry (SITA fast strategy, program
30–2,  model  750;  Humphrey  Field  Analyzer;  Carl  Zeiss
Meditec, Dublin, CA) that is consistent with glaucomatous
optic nerve damage. This was defined as Glaucoma Hemifield
test results outside normal limits and/or an abnormal pattern
standard deviation (SD) with p<5% occurrence in the normal
population;
(3) a closed angle on indentation gonioscopy. A closed
angle was defined as the presence of at least a 180° angle in
which the posterior pigmented trabecular meshwork (TM)
was not visible on gonioscopy and with evidence of peripheral
anterior synechiae in any part of the angle.
Patients  were  excluded  if  they  had  secondary  angle
closure or a personal history of hypertension, diabetes, or
cardiovascular disease.
Control subjects did not have a history of any of the above
symptoms  and  signs.  All  the  control  subjects  received  a
complete ocular examination, which included best corrected
visual  acuity  measurements  using  the  logarithm  of  the
minimum angle of resolution 4-m charts, slit-lamp evaluation
of the anterior segment, fundus examination, measurement of
IOP,  axial  length  measurement  (A-scan  ultrasonography,
Quantel Medical, Clermont-Ferrand, France), and detailed
TABLE 1. PRIMER PAIRS AND ENZYMES USED FOR CALCRL TAG SNP GENOTYPING.
dbSNP ID                    Forward primer Reverse primer
Product length
(bp)
Tm               Restriction
 (°C)                  enzyme
rs7591567 GTCACGCTGAGGTAGG GATTTCATTTGCCACC 485 56 BstZ171
rs3771073 CAGAATGTAGCAGGAC CTCTAAAGGGATGGTT 215 51 Ddel
rs3821181 GATACCTAGGGAACCA ACAACAGCGAAACATT 280 51 AflII
rs9288141 CCTGCAAGACAATCCC ATCCGACAAGGTGAGC 381 56.6 HpaII
rs1157699 GATGAAAGCCTGAGAA ACCTGCCTCCATACTC 165 52.4 BanII
rs6759535 TTTATTGAGTGCCTAC AAATGGACCATGTTTA 381 50.3 HpaII
rs840617 TCCATTGGCTAAGTCC CCCTTACCCTTTCCAG 353 54.3 HpyCH4IV










 (n=98) p value
Gender Female 138 (67%) 75 (68.8%) 0.788 64 (65.3%) 0.728
  Male 67 (33%) 34 (31.2%)   34 (34.7%)
Age Mean±SD 67.12±7.89 65.91±8.66 0.654 65.59±7.16 0.677
  Range 50-80 45-95   43-85
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p valuerecording of the health and degree of cupping of the optic
nerve head. All control subjects had open angles, IOPs of <21
mmHg, normal optic nerve heads with cup-to-disc ratio of
≤0.5, no family history of glaucoma, no ophthalmic diseases
except  cataract,  and  no  personal  history  of  hypertension,
diabetes, or cardiovascular diseases.
DNA  Preparation:  DNA  samples  of  PACG  patients  and
controls were prepared from leukocytes of peripheral venous
blood  using  the  phenol-chloroform  extracted  method  and
stored at –80 °C until use.
Tag  Single  Nucleotide  Polymorphism  Selection  and
Genotyping: The Tagger program in Haploview 4.1 was used
for selecting tag SNPs. In order to cover most of the genetic
variability of the CALCRL gene, tag SNPs were chosen using
pair-wise  tagging,  Hardy–Weinberg  equilibrium  p  value
cutoff 0.05, r2 cutoff >0.8, minimum minor allele frequency
>0.1, and population CHB (Han Chinese in Beijing, China)
+JPT (Japanese in Tokyo, Japan). Finally we chose seven tag
SNPs  suggested  by  the  Tagger  program,  which  captured
87.7% of common CALCRL SNPs in the Hapmap database.
These proposed tag SNPs were: rs7591567 [C/T] at intron 1,
rs3821181 [C/G] at intron 1, rs9288141 [A/G] at intron 1,
rs1157699  [C/T]  at  intron  1,  rs840617  [A/T]  at  intron  8,
rs6759535 [C/T] at intron 8, and rs3771073 [C/G] at intron 1.
The latter two tag SNPs were used in exchange for rs3771081
(D'=1, r2=1.0) and rs12104503 (D'=1, r2=0.905), respectively.
All seven tag SNPs were genotyped by PCR restriction
fragment length polymorphism (PCR-RFLP). The primers of
the  seven  sites  were  designed  using  Primer  Premier  5.0
software (Premier Biosoft International, Palo Alto, CA). The
details  of  the  primers  and  enzymes  used  for  PCR-RFLP
genotyping are presented in Table 1.
The  PCR  reaction  was  performed  in  a  thermocycler
(Biometra,  GoÈttingen,  Germany)  under  the  following
conditions: an initial denaturation at 95 °C for 5 min followed
by  33  to  35  cycles  of  95  °C  for  30  s,  proper  annealing
temperature for 30 s, and 72 °C for 30 s. The final extension
cycle of 72 °C was for 5 min. The PCR products were then
digested by the proper restriction enzymes (New England
Biolabs, Inc., Beijing, China). Digestion products were loaded
Figure 1. The haplotype block structure
and the position of the studied tag single
nucleotide polymorphisms of CALCRL.
The relative physical position of each
tag  single  nucleotide  polymorphism
(SNP)  is  given  together  with  the  rs
number in the upper part of the diagram.
Pair-wise SNP D’ values (multiply by
100) of linkage are shown together with
two  identified  haplotype  blocks.  The
bright red rectangles represent D’=100
(multiply by 100).
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gel and resolved at 35 W for about 1.5 h. The images were
recorded digitally.
Statistical Analysis: Statistical analysis was performed with
SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL). The
Hardy–Weinberg equilibrium was tested by the χ2 test. We
evaluated the frequency of genotypes and alleles in this study
using the χ2 test or Fisher’s exact test (p values <0.05 were
considered significant). The haplotype frequency and linkage
disequilibrium of the SNPs were estimated with Haploview
4.1. A haplotype frequency <0.03 was not studied further. All
the data were corrected by Bonferroni correction.
RESULTS
There was no difference between the control group and the
patients with PACG in gender and age, as shown in Table 2.
Seven tag SNPs in CALCRL were determined in patients and
controls. The polymorphism at rs3821181 was not detected in
all 412 subjects (C/C genotype in all subjects), so it was
excluded in the following comparisons. The other six SNPs
were  in  Hardy–Weinberg  equilibrium  in  APACG  and
CPACG, as well as in controls (p>0.05). The haplotype block
structure, together with D’ values and the position of the
studied tag SNPs of CALCRL, are shown in Figure 1.
Single marker analysis: Allele and genotype frequency
comparisons  between  APACG  patients  and  controls
demonstrated nominally significant differences with p values
of 0.024 and 0.028, respectively, for the C/T polymorphism
at intron 1 (rs1157699), but this significance was lost after
Bonferroni correction (corrected p value 0.144 and 0.168,
respectively). No significant difference in the remaining five
SNPs  tested  was  observed  between  APACG  patients  and
controls in the distribution of alleles and genotypes (Table 3
and Table 4), and none of the six SNPs were significantly
associated with CPACG (Table 3 and Table 4).
Haplotype  analysis:  Pair-wise  linkage  disequilibrium
between the six tag SNPs is shown in Figure 1. We identified
two  haplotype  blocks.  In  block  1  the  frequency  of  the
Trs840617Crs6759535Trs1157699 haplotype was significantly higher in
APACG  patients  than  controls  (18.2%  versus  9.0%,
respectively p=0.0015, Bonferroni corrected p=0.012; Table
5), and the frequency of haplotype Trs840617Crs6759535Crs1157699
was significantly lower in APACG patients compared with
controls  (31.9%  versus  42.4%  respectively,  p=0.0028,
Bonferroni  corrected  p=0.02;  Table  5).  No  association
between other haplotypes and CPACG was found (data not
shown).
DISCUSSION
Adrenomedullin  (AM),  a  52-amino  acid  smooth  muscle-
relaxing polypeptide, is produced in several tissues, including
the eye [16]. In human eyes, AM has been identified in the
aqueous humor that is produced by the iris ciliary body [17].
Studies  in  several  mammalian  species,  including  humans,
have identified the pupillary sphincter as a target of ocular AM
[18], and AM receptors linked to cAMP production have been
identified [19]. The AM receptor is a complex molecule that
consists of CALCRL and receptor activity–modifying protein
2 (RAMP2). CALCRL is a G protein-coupled receptor with
seven  transmembrane  domains.  The  mechanism  for  its
activation  is  unique;  CALCRL  is  transported  from
endoplasmic  reticulum  to  the  cell  membrane  by  RAMP2
where it is core glycosylated to become a receptor for AM
[20].  The  gene  encoding  CALCRL  contains  15  exons
interrupted by 14 introns, including one that spans more than
60  kilobases.  Exons  1–3  constitute  the  noncoding  region;
TABLE 3. FREQUENCY OF GENOTYPES OF SIX CALCRL SNPS IN PACG PATIENTS AND CONTROLS.
dbSNP ID                Genotype Control n (%) APACG n (%) p Value CPACG n (%) p Value
rs7591567 CC 5 (2.4%) 3 (2.8%) 0.779 2 (2%) 0.368
  CT 53 (25.9%) 32 (29.4%)   33 (33.7%)
  TT 147 (71.7%) 74 (67.9)   63 (64.3%)
rs3771073 CC 4 (2%) 2 (1.8%) 0.343 1 (1%) 0.509
  CG 57 (27.8%) 39 (35.8%)   33 (33.7%)
  GG 144 (70.2%) 68 (62.4%)   64 (65.3%)
rs9288141 AA 128 (62.4%) 68 (62.4%) 0.816 61 (62.2%) 0.951
  AG 72 (35.1%) 37 (33.9%)   34 (34.7%)
  GG 5 (2.4%) 4 (3.7%)   3 (3.1%)
rs1157699 CC 138 (67.3%) 57 (52.3%) 0.028 60 (61.2%) 0.415
  CT 60 (29.3%) 48 (44%)   32 (32.7%)
  TT 7 (3.4%) 4 (3.7%)   6 (6.1%)
rs6759535 CC 95 (46.3%) 56 (51.4%) 0.469 50 (51%) 0.742
  CT 97 (47.3%) 44 (40.4%)   42 (42.9%)
  TT 13 (6.3%) 9 (8.3%)   6 (6.1%)
rs840617 AA 18 (8.8%) 12 (11%) 0.494 5 (5.1%) 0.488
  AT 79 (38.5%) 35 (32.1%)   37 (37.8%)
  TT 108 (52.7%) 62 (56.9%)   56 (57.1%)
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14 encode seven transmembrane domains [21].
Previous animal studies have demonstrated that the AM
gene is associated with abnormalities of vascular function or
hypertension  [22,23].  However  mice  that  overexpressed
CALCRL in smooth muscle-containing tissues had increased
CALCRL/RAMP2 (AM receptors) in the pupillary sphincter
muscle, resulting in enhanced AM-induced sphincter muscle
relaxation. Importantly, certain transgenic mice had acutely
and transiently elevated IOP between 1 and 3 months of age
before  chronically  elevated  IOP  became  evident.  This
indicates  that  overexpression  of  CALCRL  can  lead  to
increased sensitivity of the sphincter muscle to endogenous
AM, thus causing chronic relaxation of the sphincter muscle
TABLE 4. FREQUENCY OF ALLELES OF SIX CALCRL SNPS IN PACG PATIENTS AND CONTROLS.
dbSNP ID Allele Control n (%) APACG n (%) p value
APACG, n(%)
rs7591567 C 63 (15.4%) 38 (17.4%) 0.502
  T 347 (84.6%) 180 (82.6%)
rs3771073 C 65 (15.9%) 43 (19.7%) 0.221
  G 345 (84.1%) 175 (80.3%)
rs9288141 A 328 (80%) 173 (79.4%) 0.849
  G 82 (20%) 45 (20.6%)
rs1157699 C 336 (82%) 162 (75.2%) 0.024
  T 74 (18%) 56 (24.8%)
rs6759535 C 287 (70%) 156 (71.6%) 0.683
  T 123 (30%) 62 (28.4%)
rs840617 A 115 (28%) 59 (27.1%) 0.792
  T 295 (72%) 159 (72.9%)
CPACG, n(%)
rs7591567 C 63 (15.4%) 37 (18.9%) 0.276
  T 347 (84.6%) 159 (81.1%)
rs3771073 C 65 (15.9%) 35 (17.9%) 0.534
  G 345 (84.1%) 161 (82.1%)
rs9288141 A 328 (80%) 156 (79.6%) 0.910
  G 82 (20%) 40 (20.4%)
rs1157699 C 336 (82%) 152 (77.6%) 0.201
  T 74 (18%) 44 (22.4%)
rs6759535 C 287 (70%) 142 (72.4%) 0.535
  T 123 (30%) 54 (27.6%)
rs840617 A 115 (28%) 47 (24%) 0.289
  T 295 (72%) 149 (76%)






(frequence) Fisher’s p Corrected p     Odds ratio (95% CI)
block 1 ACC 35.04 (0.161) 59.35 (0.145) 0.7395 NS 1.08 (0.69-1.70)
  ACT 11.79 (0.054) 16.71 (0.041) 0.5117 NS 1.29 (0.60-2.77)
  ATC 9.73 (0.045) 26.85 (0.065) 0.2398 NS 0.64 (0.30-1.36)
  TCC 69.44 (0.319) 174.03 (0.424) 0.0028 0.02 0.59 (0.42-0.83)
  TCT 39.74 (0.182) 36.92 (0.090) 0.0015 0.012 2.16 (1.33-3.50)
  TTC 49.80 (0.228) 75.78 (0.185) 0.2881 NS 1.25 (0.83-1.86)
block 2 CC 28.25 (0.130) 39.51 (0.096) 0.2014 NS 1.40 (0.84-2.33)
  CT 14.75 (0.068) 25.49 (0.062) 0.7894 NS 1.10 (0.56-2.13)
  GC 9.75 (0.045) 23.49 (0.057) 0.5028 NS 0.77 (0.36-1.66)
  GT 165.25 (0.758) 321.51 (0.784) 0.4552 NS 0.86 (0.58-1.27)
95% CI=95% confidence interval; NS=not significant.
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Haplotypeand, as a consequence, obstruction of the aqueous outflow
system.
In humans, PACG is characterized by reduced anterior
chamber depth and increased lens thickness. In structurally
predisposed eyes, drug-enhanced dilation of the pupil in dim
light can provoke PACG [24,25]. Interestingly, dark-adapted
transgenic mice exhibited impaired pupillary constriction in
response to light exposure. However, topical administration
of the AM antagonist AM-(20–50) normalized the pupillary
response to light stimulation in the mice, suggesting an AM-
mediated functional defect of the sphincter muscle. Taken
together  we  expected  that  the  degree  of  expression  of
CALCRL and the receptor activity of its product would affect
the occurrence or development of angle closure glaucoma.
To our knowledge, this has been the first study to date
investigating relationships between SNPs in CALCRL and
PACG in a southern Chinese population. The results show
rs1157699  is  nominally  associated  with  APACG  with  a
marginal significance (uncorrected p value 0.024 and 0.028
observed in allele and genotype analyses, respectively, of this
site).  Moreover,  our  study  suggests  that  the  haplotype
Trs840617Crs6759535Trs1157699 is positively associated with APACG
and  that  the  haplotype  Trs840617Crs6759535Crs1157699  might  be  a
protective haplotype for APACG. However we did not find
any  evidence  of  association  between  common  variants  of
CALCRL and CPACG.
In single-marker analysis, we observed that the Trs1157699
allele is significantly more common in APACG patients than
controls (uncorrected p=0.02), indicating a possible protective
role of the Crs1157699 allele. Although rs1157699, which locates
in the first intron of CALCRL, is not a functional SNP, it could
have other effects, such as influencing splicing or regulatory
processes by affecting the binding of transcription factors to
the gene. Furthermore, as a tag SNP, the polymorphism is
representative  of  many  other  variants,  which  could  be
regulatory in the function of the receptor. Also, it may be in
linkage disequilibrium with functional variants.
With regard to the haplotype analysis, we found two
haplotypes  Trs840617Crs6759535Trs1157699  and
Trs840617Crs6759535Crs1157699 that are associated with APACG. The
former  was  found  to  be  significantly  higher  in  APACG
patients, while the latter was found to be lower in APACG
patients. The haplotype association with APACG could be a
result  of  the  presence  of  the  Trs1157699  allele,  providing
significance  to  the  implicated  block.  This  explanation  is
supported by the fact that the allele frequencies of the other
two tag SNPs constructing this haplotype are similar in the
investigated  populations.  Furthermore,  the  haplotype
association  is  statistically  significant  after  the  Bonferroni
correction.
To  our  knowledge,  this  is  the  first  molecular
epidemiology  study  suggesting  a  possible  association
between CALCRL polymorphisms and APACG risk. Despite
the  significance  of  SNP  rs1157699  not  withstanding
correction for multiple testing, the results of our exploratory
analysis warrant further studies.
The  lack  of  association  between  the  tag  SNPs  and
CPACG suggests that CALCRL is not a significant risk factor
for its development. This may be because the mechanism
causing CPACG is much more complicated than APACG
[26]. In APACG attack, sphincter muscle palsy occurs and the
pupil  dilates,  resulting  in  pupillary  block.  With  CPACG,
multiple  mechanisms  are  involved,  for  example,  closer
location of iris root insertion to the angle and thicker and
fleshier  peripheral  irises  and  anteriorly  positioned  ciliary
bodies.  Based  on  the  above  reasons,  CPACG  might  be
genetically different from APACG.
In conclusion, this study shows a possible association
between CALCRL and APACG, and CALCRL may not play a
major role in the etiology of CPACG. Additional replication
studies are necessary to confirm such association.
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